Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v2-FR
Language French French
Date Updated 2020-01-30 2019-08-14
Drug Identification Number 02468514 02468514
Brand name DEXTROSE INJECTION USP DEXTROSE INJECTION USP
Common or Proper name DEXTROSE INJECTION DEXTROSE INJECTION
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients DEXTROSE DEXTROSE
Strength(s) 500 mg/mL 500 mg/mL
Dosage form(s) Solution Solution
Route of administration Intravenous Intravenous
Packaging size 10 X 50ml ANSYR 10 X 50ml ANSYR
ATC code B05BA B05BA
ATC description I.V. Solutions I.V. Solutions
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-08-14 2019-08-14
Estimated end date Unknown
Actual end date 2020-01-29
Shortage status Resolved Anticipated shortage
Company comments Current inventory is on preventative allocation
Health Canada comments